CompletedNot Applicable

Effectiveness of A Stigma Directed Interventional Program in Schizophrenia

Egypt80 participantsStarted 2019-04-16

Plain-language summary

randomized controlled study measuring the effectiveness of Stigma focused intervention in patients suffering from Schizophrenia

Who can participate

Age range18 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients meet the diagnosis of schizophrenia or schizoaffective disorder according to DSM5.The clinical condition is stabilized.
✓. Age range between 18 to 50 years.
✓. Male and female sexes are included.
✓. Availability of close relative in direct contact with the patient.
✓. Primary caregiver and the family member share household with patient.
✓. No history of receiving treatment of psychiatric disorders.
✓. No history of serious head trauma.

Exclusion criteria

✕. Co morbid substance abuse or dependence disorder.
✕. Co morbid intellectual disability.
✕. Co morbid chronic medical or neurological condition or history of serious head trauma.
✕Sever physical illness that hinders their participation- -

What they're measuring

change in Self-Stigma using the Arabic version of the internalized stigma of mental illness scale

Timeframe: Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment

change in perceived family burden using the perceived family burden scale

Timeframe: Baseline assessment---- followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) Final assessment after 3 months from point 1 Assessment

change in medication adherence using customized chart for each patient

Timeframe: Baseline assessment followed by Point 1 Assessment at the end of the 8 weekly sessions of the program ( after 2 months from baseline assessment) fFinal assessment after 3 months from point 1 Assessment

Trial details

NCT IDNCT03930225

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-06-30

View on ClinicalTrials.gov More Schizophrenia trials